Area of research
Otorhinolaryngology · Radiology, Nuclear Medicine and Imaging
Research interest
Research focused on Nasopharyngeal carcinoma and Erlotinib, with related work in Overfitting, Repeatability, Ramucirumab. Notable publications include 'Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a randomised, double-blind, placebo-controlled, phase 3 trial', 'Ninth Version of the AJCC and UICC Nasopharyngeal Cancer TNM Staging Classification', and 'Integration of an imbalance framework with novel high-generalizable classifiers for radiomics-based distant metastases prediction of advanced nasopharyngeal carcinoma'.
Ninth Version of the AJCC and UICC Nasopharyngeal Cancer TNM Staging Classification
Radiomic feature repeatability and its impact on prognostic model generalizability: A multi-institutional study on nasopharyngeal carcinoma patients
Multimodal Data Integration to Predict Severe Acute Oral Mucositis of Nasopharyngeal Carcinoma Patients Following Radiation Therapy
Quantitative Spatial Characterization of Lymph Node Tumor for N Stage Improvement of Nasopharyngeal Carcinoma Patients
Integration of an imbalance framework with novel high-generalizable classifiers for radiomics-based distant metastases prediction of advanced nasopharyngeal carcinoma
Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a randomised, double-blind, placebo-controlled, phase 3 trial